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Micro Abstract 
The early oncological goal of any partial nephrectomy is to achieve negative surgical margins. 
Several factors have been advocated as predictors of PSMs after NSS. In our study, age, upper pole 
tumor location, standard PN and Fuhrman 3-4 nuclear grade were found to be independent 
predictors of PSMs at multivariable analysis. Further evaluation are required to verify the 
oncological impact of the PSM on local and systemic recurrence. 
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Abstract 
Purpose. To evaluate the predictors of positive margins in one of the largest available prospective 
multi-institutional study. 
Material and Methods. We evaluated all patients who underwent nephron sparing surgery for 
radiologically diagnosed kidney tumors between January 2009 and December 2012 at 19 
urological Italian centers (RECORd project). Preoperative and anthropometric data, co-morbidities,  
intra-operative and post-operative outcomes and histological findings were analysed. The negative 
and positive SM were compared according to the clinical and surgical variables. Multivariable 
logistic regression models were applied to analyse predictors of PSM. 
Results. Eight hundred consecutive patients were evaluated. 761 (95.1%) and 39 patients (4.9%) 
achieved negative and positive surgical margins, respectively. Patients with PSMs were 
significantly older compared to those with negative margins (median age: 66.6 vs. 61.8 years, 
respectively, p=0.001). A higher incidence of PSMs was observed when NSS was performed for 
renal masses located in the upper pole (p=0.001). A lower rate of PSM was found in those patients 
treated with simple enucleation rather than standard partial nephrectomy (1.6% vs. 7.4% 
respectively, p<0.0001). Higher incidence of PSMs was found in Fuhrman 3-4 tumors (11.3%, 
p<0.0001). At multivariable analysis, age (OR: 1.04, p=0.01), upper pole tumor location (OR: 2.85, 
p=0.005), standard PN (OR: 3.45, p=0.004) and Fuhrman 3-4  nuclear grade (OR: 4.81, p=0.001) 
were found to be independent predictors of PSMs. 
Conclusions. In our multi-institutional report, young age, simple enucleation, middle or lower 
tumor location and low grade tumor demonstrated to be independent predictors of negative 
surgical margins. 
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Introduction 
Nephron-sparing surgery (NSS) has become the standard of care for the conservative management 
of clinically localized renal cell carcinoma (RCC) whenever technically feasible [1,2], offering 
equivalent oncological results [3,4] and lower renal function impairment [5,6] in comparison to 
radical nephrectomy. The excision of the tumor with a minimal margin of healthy parenchyma 
surrounding the neoplasm is currently considered the standard technique for partial nephrectomy 
(PN), in order to minimize the risk of positive surgical margins (PSM) and achieve optimal local 
cancer control [1]. In recent years, large series have reported the results of simple enucleation (SE) 
of renal masses showing equivalent functional and oncological results to standard PN [7]. In all 
cases, NSS may result in incomplete cancer removal, thus causing PSM, which may need additional 
follow up and  can lead to a potentially increased risk of local recurrence and disease progression 
[8-10]. In the absence of randomized trials providing strong clinical evidences, several factors have 
been advocated as predictors of PSM after NSS, such as tumor size [11], pathological stage [9], 
Fuhrman grade [12], indication to NSS (elective vs. imperative) [11] and  surgical volume [13]. 
Conversely, the surgical approach (open vs. minimally invasive), as well as surgical technique 
(Standard PN vs. SE), appear to be unrelated to margins status, according to the largest currently 
available evidences [7, 14-18]. We aimed to evaluate the predictors of PSM after NSS for RCC in 
one of the largest available prospective multi-institutional study. 
Material and Methods 
The Italian Registry of Conservative Renal Surgery (RECORd Project) is a 4-Year prospective 
observational multicenter study promoted by the Leading Urological No profit foundation 
Advanced research (LUNA) of the Società Italiana di Urologia (SIU). The RECORd project includes all 
patients who underwent conservative surgical treatment for radiologically diagnosed kidney 
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tumors between January 2009 and December 2012 at 19 urological Italian centers, upon the 
approval of the study protocol by the local ethical committee and patients acceptance of the 
written informed consent. Overall, information about 1055 patients were collected. In the present 
study only malignant lesions were analysed and 255 (24.2%) cases with benign histology were 
excluded. An online database was generated and it comprises 5 main folders: 1) anthropometric 
and preoperative data; 2) imaging, indications and co-morbidities; 3) intra-operative data; 4) post-
operative data; 5) histological analysis. All data were centrally recorded on a data server. All 
preoperative anthropometric characteristics were collected: gender, age, body mass index (BMI). 
Surgical indications were defined as elective (localized unilateral RCC with healthy contra-lateral 
kidney), relative (localized unilateral RCC with the coexistence of co-morbidities such as diabetes, 
hypertension or lithiasis that could potentially affect kidney function in the future) and absolute 
(bilateral tumors, multiple tumors, moderate to severe chronic kidney disease or in case of 
neoplasia involving an anatomically or functionally solitary kidney). Performance status was 
assigned according to the Eastern Cooperative Oncology Group (ECOG) criteria [19]. Mode of 
presentation was distinguished according to the Patard classification [20]. In all patients clinical 
workup included at least abdominal computed tomography (CT) scans and chest X-rays. Chest and 
brain CT scans were obtained only when indicated by signs and symptoms. Tumors were classified 
according to their location on the longitudinal plane (upper pole, middle part, and lower pole) and 
on the transverse plane (anterior surface, posterior surface, lateral margin, medial margin, peri-
hilar) of the kidney. According to the degree of depth into the kidney, tumors were also subdivided 
into three growth pattern categories: 1) prevalently (≥50%) exophytic, 2) prevalently endophytic 
(<50% exophytic), and 3) entirely endophytic. All intra-operative data including centre surgical 
volume, surgical approach and technique, the decision whether or not to clamp the renal vessels, 
type of ischemia, ischemia time, esteemed intra-operative blood loss (EBL) and operative time 
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were recorded. Analysing full dataset of 1055 cases, centres were divided in low- and high-volume, 
low and very high-volume according to the threshold of 50 and 65 interventions of NSS per year, 
respectively. The minimally invasive (video laparoscopic or robot assisted) and open approaches as 
well as the surgical technique, performed in the form of standard PN and SE, were adopted 
according to the centres’ and surgeons’ preference. Standard PN has been defined as the excision 
of the tumor comprising a minimal margin of healthy peritumoral renal parenchyma [7]. SE has 
been defined as the blunt tumor excision without removing a visible rim of parenchymal tissue 
around the pseudocapsule [7]. All surgical specimens were processed according to standard 
pathological procedures at each institution by experienced uro-pathologists. For surgical margins 
evaluation the specimens were fixed in 10% buffered formalin, and grossly analysed. The size, the 
colour, the gross aspect (solid to cystic) were recorded and the surgical margin was marked with 
ink. After tumor dissection, samplings were performed in order to obtain tissue blocks where 
tumor, healthy parenchyma, and surgical edges were comprised and further blocks with tumor, 
renal capsule and peritumoral fat were enclosed. The margin was considered positive when tumor 
tissue was marked with ink. The margin was considered negative when no-neoplastic renal tissue 
was observed on the inked edges. Tumors were pathologically staged according to the American 
Joint Committee on Cancer TNM classification [21]. The renal epithelial neoplasms classification, 
outlined in the 2004 WHO monograph, was used to assign the histological type [22]. The Fuhrman 
classification was used to assign the nuclear grade [22]. No central pathological slide review was 
performed. All the postoperative medical and surgical complications, occurring within 30 days, 
were recorded. The severity of surgical complications was graded according to the modified 
Clavien system [23].  
Statistical Analysis 
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Categorical variables were reported as number and percentage. Continuous variables were 
reported as mean (SD) or as median and IQR, as appropriate. The Student t test and the Mann-
Whitney U test were used to compare continuous variables and the Pearson’s chi square test was 
used to compare categorical variables. The negative and positive SM were compared according to 
the clinical and surgical variables. Multivariable logistic regression models considering factors that 
were significantly related to SM status at univariable analysis were applied to analyse predictors of 
PSM. Statistical significance in this study was set as p ≤ 0.05. All reported p values are two-sided. 
Analyses were performed with SPSS version 20.0 (SPSS Inc, Chicago, IL, USA). 
 
Results 
Overall, 800 patients were evaluated. Table 1 reports the clinical characteristics of the 
entire cohort according to the surgical margin status: 761 (95.1%) achieved negative surgical 
margins (NSM), while 39 patients (4.9%) had PSMs at the final pathological examination. Patients 
with PSM were significantly older compared to those with NSM (median age: 66.6 vs. 61.8 years, 
respectively, p=0.001). Conversely, no statistically significant differences were found among 
patients with positive and negative margins in terms of gender, BMI, indication to NSS 
(elective/relative vs. imperative), symptoms at the time of diagnosis, ECOG performance status, 
number of lesions, clinical stage and tumor side. Median (IQR) clinical diameter was 3.3 (2.3-4) cm 
and 3.2 (2.0-3.9) cm in those patients with NSM and PSM, respectively (p=0.6). A significantly 
higher incidence of PSMs was observed when NSS was performed for renal masses located in the 
upper pole compared with mesorenal or lower pole tumors (p=0.001). On the contrary, the tumor 
growth pattern (exophytic/endophytic) and localization (anterior, posterior, medial, lateral) did 
not significantly affect the surgical margins status.  
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Table 2 summarizes the most relevant intra-operative data. The incidence of PSMs was 
significantly lower after minimally invasive NSS compared to open procedures (3.0% vs. 6.2% 
respectively, p=0.04). According to the adopted surgical technique, a lower rate of PSM was found 
in those patients treated with SE rather than standard PN (1.6% vs. 7.4% respectively, p<0.0001). 
Conversely, margin status was not significantly affected by the centre's surgical volume, 
considering both low- vs. high-volume centres and low- vs. very high-volume centres. Margin 
status was not significantly affected by operative time, EBL, hilar clamping, ischemia time and 
intra-operative complications. Furthermore, no significant differences in terms of tumor histotype, 
pathological diameter and pathologic tumor evaluation (intra-capsular vs. extra-capsular) were 
found among patients with negative and positive surgical margins, respectively (Table 3); 
interestingly, the incidence of PSM was higher in Fuhrman 3-4 tumors when compared to those 
with lower nuclear grade (11.3% vs. 3.1% respectively, p<0.0001, Table 3).  
Results from multivariable logistic regression analysis considering factors that were 
significantly related to SM status are summarized in Table 4. Age (OR: 1.04, p=0.01), upper pole 
tumor location (OR: 2.85, p=0.005), standard PN (OR: 3.45, p=0.004) and Fuhrman 3-4  nuclear 
grade (OR: 4.81, p=0.001) were found to be independent predictors of PSMs. Conversely, the 
surgical approach (open vs. minimally invasive) was not an independent variable (OR: 1.36, 
p=0.48) at multivariable analysis. 
  
 
Discussion 
When performing NSS for RCC, the complete removal of the tumor and the avoidance of 
PSMs is of paramount importance, to reach optimal long-term oncological control [1]. Currently, 
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the incidence of PSM after elective NSS ranges from 0% to 7% [10]. Our series report an overall 
incidence of PSMs of 4.9%, which is comparable to the results of other NSS series, regardless of 
the surgical approach (open vs. minimally invasive) [9]. To our knowledge, this is one of the 
largest, multi-institutional prospective study evaluating the predictors of positive surgical margin 
and it is the first that included both open and minimally invasive NSS in the analyses. 
In our multi-institutional study, the PSMs rate was slightly higher in those patients treated 
with open rather than minimally invasive (either laparoscopic or robot-assisted) NSS at univariable 
analysis (6.2% vs. 3.0%, respectively, p=0.04). Conversely, the surgical approach failed to confirm 
its independent role as predictor of PSM at multivariable analysis (Table 4). In a recent matched-
pair analysis comparing open and robot-assisted PNs from 23 centres, Ficarra et al. found no 
significant difference in PSM rate among open (5.5%) and robot-assisted (5.7%) PN (p=0.98) [16]. 
Similarly, Springer and coworkers, showing results from a retrospective single-institutional study 
of 340 open and laparoscopic PN for cT1 RCC, found comparable incidence of PSMs between the 
two groups (1.7% vs. 1.2%, p=0.09) [24].  
It appears still controversial whether the age at the time of surgery could be a predictor of 
PSMs. In our report, the rate of positive margins were found to be slightly higher in those patients 
older than 65 years, even if this data was not statistically significant at univariable analysis (Table 
1, p=0.07). Conversely, at the multivariable logistic regression analysis, age as continuous value 
demonstrated to be significant and independent predictor of PSMs (OR: 1.04, p=0.01, Table4). 
Such result could be easily explained. Basically, in older patients renal function could be much 
more impaired because of medical or cardiovascular co-morbidities than younger counterparts. In 
this scenario, urologists attempt to spare as much healthy parenchyma as possible during NSS, in 
order to minimize the loss of postoperative renal function, thus increasing the risk of PSMs. This 
result is different than other reported in Literature. Ani et al. found that age was not 
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independently associated with the higher risk of PSMs at multivariable analysis (OR: 0.99, p=0.3) 
[9]. Similarly, Yossepowich and co-workers did not found any correlation between age and surgical 
margin status at both univariable (OR: 1, p=0.77) and multivariable (OR: 1, p=0.81) analysis [11]. 
 Despite the previous, historical recommendations to remove at least 1 cm of normal 
appearing renal parenchyma around the tumor in order to ensure negative margins [25], the 
current indications for NSS have been progressively changed: indeed, according to the recognized 
oncological safety of NSS even for T1b RCC [3, 26] and to the need for preservation of as much 
functioning healthy parenchyma as possible to minimize the loss of renal function [27], NSS has 
moved from maximal parenchymal resection to a minimal tissue removal [20]. In this scenario, 
several non-randomized studies demonstrated the oncological safety of simple tumor enucleation 
in comparison to standard PN for the treatment of cT1 RCC, with a quite lower incidence of PSMs 
with respect to those observed after standard PN  [7,28,29]. Minervini et al, in the retrospective 
SATURN study, found a PSM rate of 0.2% and 3.4% after SE and traditional PN, respectively 
(p<0.001) [7]. Similarly, in our study the incidence of PSM was significantly lower in those patients 
treated with SE (p<0.0001, Table 1), even at multivariable analysis the surgical technique was 
confirmed as an independent of PSM  (OR: 3.45, p=0.004, Table 4). The reason of such results, 
however, should be carefully analyzed. In fact, the blunt enucleation of the tumor along the 
inflammatory pseudocapsule, rather than a traditional resection of the surrounding healthy 
parenchyma, could allow to a better respect the natural cleavage plane, avoiding entering within 
the mass in case of irregular shape and leaving positive margins behind. Moreover, an extensive 
and established experience of surgeons performing SE in this series could be another possible 
explanation of such result. Therefore, present data should be regarded at least as a proof of non- 
inferiority in terms of local cancer control of SE versus standard PN but prospective randomized 
series are awaited to shed light on this oncological issue.  
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Longitudinal location (polar vs. mesorenal), exophytic, hilar location and clinical dimension 
of the tumor (parameters that belong to the PADUA classification) [30] could be significant pre-
operative factors able to predict the complexity of the NSS and could be related to the risk of 
complications as well as of PSM. It seems reasonable that, the higher is the surgical complexity, 
the more challenging is to achieve local control and complete resection. In our study, the rate of 
PSM after NSS was significantly higher only for upper polar tumors, rather than mesorenal or 
lower polar lesions (9.3% vs. 2.6% vs. 3.8%, respectively, p=0.001). Moreover, the polar location 
(superior vs. mesorenal/inferior) demonstrated to be an independent predictor of PSM at 
multivariable analysis (OR: 2.85, p=0.005, Table 4). A worse exposure of the surgical field in the 
upper pole tumors in both right and left side tumors may render  the resection of the tumor more 
difficult, especially when performing minimally invasive procedures. To our knowledge, no 
previous series reported a correlation between tumor polar location and the risk of PSM. 
Nevertheless, in the present series, the rate of PS  was not influenced by the tumor growth 
pattern, the hilar location and the rim location. This agrees with the data reported by other 
recently published papers. Khalifeh and coworkers, in a multi-institutional, retrospective study of 
943 consecutive robot-assisted PN, showed that surgical margin status was not significantly 
compromised by the hilar location, endophytic rate and the tumor complexity according to the 
nephrometric score [7].  
Currently, there are no convincing correlations among tumor size, clinical stage and 
incidence of PSM after NSS. Yossepowitch et al. retrospectively evaluated a cohort of 1390 
patients with a mean tumor diameter of 3.5 cm, demonstrating that increasing tumor size was 
associated with a lower incidence of positive margins both at univariate and multivariate analyses 
(P=0.05) [10]. Conversely, comparable incidence of PSM between patients with tumors ≤ 4 cm and 
> 4 cm has been found in other retrospective open and laparoscopic series [31,32]. In a recent 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
14 
 
report from the Ontario Cancer Registry evaluating 788 open and laparoscopic PNs, Ani et al. 
found significant correlations between increasing tumor size and margin status, with a 4-fold 
higher risk of PSM in pT1b tumors (p=0.002) [8]. In our study the mean tumor dimension and the 
clinical and pathological stage failed to correlate with PSM status. This finding corroborate the 
oncological safety of NSS even in cT1b renal tumors, regardless of the surgical approach and 
technique adopted.  
The correlation between high nuclear grade and the incidence of PSM still remains 
controversial. Intuitively, the presence of more aggressive and infiltrative cancer with irregular 
shape and infiltrative growth pattern may render the tumor dissection more challenging thus 
enhancing the incidence of PSM. Higher nuclear grade and more unfavourable cancers have been 
shown to be related to the complexity of the renal tumors, according to their anatomical and 
topographic characteristics [33]. In the present study, positive margins were significantly higher in 
patients with Fuhrman 3-4 RCC compared to those with nuclear grade 1-2 (p<0.0001). 
Furthermore, higher tumor grade was found to be an independent predictor of PSM at 
multivariate analysis (OR: 4.81, p=0.001, Table 4). Bensalah et al, retrospectively evaluated a 
cohort of 775 patients treated with PN and found comparable results: a greater frequency of high-
grade tumors was found in patients with PSMs rather than in those with NSM (30% vs. 19.4%, 
respectively) [11]. Contrasting results have been recently reported in other studies [8], in which 
nuclear grade was neither associated nor independent predictor of PSMs.  
In literature, the surgical indication (elective/relative vs. imperative) demonstrated to play 
a role in the prediction of PSMs after partial nephrectomy. Yossepowitch et al, after adjusting for 
clinical tumor size, found that the imperative indication was an independent predictor of PSM 
[10]. Conversely, in the present study the incidence of PSM was not statistically influenced by the 
surgical indication. Indeed, even if the rate of positive margins was quite higher in patients treated 
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with imperative NSS (8.5%) compared to those with elective procedure (4.6%), this finding did not 
reach the statistical significance (p=0.18). However, the low number of patients treated with 
imperative indications in our report could have reduced the statistical power of our analysis.  
The actual clinical and oncological impact of PSMs after NSS is at least controversial. 
Indeed, according to the currently available evidences [10], the presence of a positive margin 
could lead to an higher risk of local recurrence in the ipsilateral kidney, especially in those patients 
with high grade tumors. Conversely, at intermediate- and long-term follow-up, the metastatic 
progression and cancer specific mortality rates were found to be comparable among patients with 
positive or negative surgical margins [10].  
We believe that the high number of patients treated and of variables analyzed, as well as 
the prospectively maintained database, are the main strengths of our study. Moreover, its 
multicenter nature might increase the external validity of the data compared with the single-
center, single-surgeon setting and provide a valid snapshot of the incidence and predictors of PSM 
in a European country in the last 4 years. As study limitations, the absence of a central 
pathological review, which would have influenced the interpretation of the specimens and the 
final diagnosis of surgical margin status, and the lack of assessment of the surgical complexity 
according to nephrometric scores  represent the most important limitations of the present paper.  
 
Conclusion 
The early oncological goal of PN is to achieve negative margins. In our multi-institutional 
report of open and minimally invasive NSS, the overall rate of PSM is 4.9%.  Older age, standard 
PN technique, upper polar tumor location and high grade tumor are all independent predictors of 
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PSMs. Further evaluation and follow-up is required to verify the oncological impact of the PSM on 
local and systemic recurrence. 
 
 
 
 
 
 
 
 
 
 
 
Clinical Practice Points 
• The excision of the tumor with a minimal margin of healthy parenchyma surrounding the 
neoplasm is currently considered the standard technique for partial nephrectomy (PN), in 
order to minimize the risk of positive surgical margins (PSM) and achieve optimal local 
cancer control 
• This study (RECORd project) includes all patients who underwent conservative surgical 
treatment for radiologically diagnosed kidney cancers between January 2009 and 
December 2012 at 19 urological Italian centers. 
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• Results from multivariable logistic regression analysis showed that age (OR: 1.04, p=0.01), 
upper pole tumor location (OR: 2.85, p=0.005), standard PN (OR: 3.45, p=0.004) and 
Fuhrman 3-4  nuclear grade (OR: 4.81, p=0.001) were found to be independent predictors 
of PSMs.  
• Conversely, the surgical approach (open vs. minimally invasive) was not an independent 
variable (OR: 1.36, p=0.48) at multivariable analysis. 
• Further evaluation and follow-up is required to verify the oncological impact of the PSM on 
local and systemic recurrence. 
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Table 1 
Clinical characteristics of the entire cohort of 800 patients according to SM status. 
Preoperative data Negative SM  (n=761; 95,2%) 
Positive SM  
(n=39; 4,8%) P 
Gender, n. % 
Male 524 94.9% 28 5.1% 
0.70 
Female 237 95.6% 11 4.4% 
Age, year  
<65 yrs n % 406 96.4% 15 3.6% 
0.07 
≥ 65 yrs n % 355 93.7% 24 6.3% 
Mean SD 61.8 12.6 66.6 8.8 0.001 
BMI, median (IQR) 28.7 24.3-28.5 26.3 23.8-27.7 0.29 
Indication, n. % 
Elective/Relative 707 95.4% 34 4.6% 
0.18 
Absolute 54 91.5% 5 8.5% 
Symptoms at 
diagnosis, n. % 
Asymptomatic 598 95.3% 29 4.7% 
0.71 
Symptomatic 163 94.4% 10 5.6% 
ECOG, n. % 
0 531 95.7% 24 4.3% 
0.28 
≥1 230 93.9% 15 6.1% 
Number of lesions 
Single 727 95.0% 38 5.0% 
0.57 
Multiple 34 97.1% 1 2.9% 
Clinical diameter, median, IQR 3.3 2.3-4.0 3.2 2.0-3.9 0.60 
Clinical T, n. % 
T1a 565 95.6% 30 4.4% 
0.93 T1b 176 95.7% 8 4.3% 
T2 20 95.2% 1 4.8% 
Tumor side, n. % 
Right 416 54.7% 19 48.7% 
0.35 
Left 345 45.3% 20 51.3% 
Tumor growth 
pattern, n. % 
≥50%Exophytic 577 94.4% 34 5.6% 
0.22 <50%Exophytic 167 97.7% 4 2.3% 
Entirely 
endophytic 17 94.4% 1 5.6% 
Tumor site, n. % 
Polar sup. 206 90.7% 21 9.3% 
0.001 Mesorenal 303 97.4% 8 2.6% 
Polar inf. 252 96.2% 10 3.8% 
Tumor localization, 
n. % 
Peri-hilar 38 95.0% 2 5.0% 
0.87 
Anterior face 230 94.3% 14 5.7% 
Posterior face 217 96.0% 9 4.0% 
Medial margin 68 97.2% 2 2.8% 
Lateral margin 207 94.5% 12 5.5% 
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Table 2 
Intra-operative data of the entire cohort of 800 patients according to SM status. 
 
 
Intraoperative data 
Negative SM  
(n=761; 95,2%) 
Positive SM  
(n=39; 4,8%) P 
Centre volume, n. % High 559 95.1% 29 4.9% 0.90 
Low 202 95.3% 10 4.7% 
Centre volume, n. % Very high 322 42.3% 20 51.3% 0.27 
Low 439 57.7% 19 48.7% 
Approach, n. % Open 442 93.8% 29 6.2% 0.04 
Minimally invasive 319 97.0% 10 3.0% 
Technique, n. % Simple Enucleation 306 98.4% 5 1.6% <0.0001 
Standard PN 
426 92.6% 34 7.4% 
Operative time, median IQR 130 105-175 147 105-185 0.49 
EBL (ml), median IQR 190 100-300 200 100-300 0.77 
Hilar clamping, n. % Not performed 278 94.2% 17 5.8% 0.37 
Performed 483 95.6% 22 4.4% 
Ischemia time, min,median IQR 16 13-20 15 11-21 0.22 
Intraoperative 
complications, n. % 
Present 45 93.7% 3 6.3% 0.64 
Absent 716 95.2% 36 4.8% 
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Table 3 
Pathological characteristics of the entire cohort of 800 patients according to SM status. 
 
Pathological data Negative SM  
(n=761; 95,2%) 
Positive SM  
(n=39; 4,8%) P 
Histotype, n % Clear cell RCC 550 95.3% 27 4.7% 0.75 
Papillary RCC 119 96.7% 4 3.3% 
Chromophobe RCC 77 96.2% 3 3.8% 
Unclassified RCC 5 71.4% 2 28.6% - 
Other renal tumors* 10 76.9% 3 23.1% - 
Pathological diameter, median IQR 3,0 2.4-4.0 3.0 2.2-4.0 0.84 
Nuclear grade, n 
%  1-2 534 96.9% 17 3.1% <0.0001 
3-4 134 88.7% 17 11.3% 
Pathologic tumor 
evaluation, n.% 
Intracapsular 702 95.5% 33 4.5% 0.07 
Extracapsular 56 90.3% 6 9.7% 
* Other renal tumors: 8 Multilocular cystic RCC, 1 Sarcomatoid RCC, 2 Translocation carcinoma (MITF/TFE family 
translocation-associated carcinoma), 1 Mucinous tubular and spindle cell carcinoma, 1 Thyroid-like follicular carcinoma of the 
kidney 
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Table 4 
Multivariable logistic regression models accounting for the significant predictors of PSM. 
 
Multivariate 
analysis for PSM 
OR CI 95% P 
Age, year 
continuous variable 
1.04 1.00-1.08 0.01 
Tumor site 
Polar superior lesion 
vs. others 
2.85 1.37-5.87 0.005 
Technique 
Standard PN vs. SE 
3.45 1.66-7.19 0.004 
Approach 
Open approach vs. 
minimally invasive 
 
1.36 0.58-3.19 0.48 
Nuclear grade 
3-4 vs. 1-2 
 
4.81 1.63-14.16 0.001 
 
 
